Related Experiment Video
Updated: May 1, 2026

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
Impaired sensorimotor gating in Fmr1 knock out and Fragile X premutation model mice
A J Renoux1, K J Sala-Hamrick2, N M Carducci2
1Department of Neurology, USA; Department of Molecular and Integrative Physiology, USA.
Fragile X syndrome (FXS) and Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) involve FMR1 gene CGG repeat expansions. This study reveals an age-dependent sensorimotor gating deficit in CGG knock-in mice, offering a new model for FXTAS research.
Area of Science:
- Neurogenetics
- Neurodegenerative Diseases
- Molecular Biology
Background:
- Fragile X syndrome (FXS) stems from CGG repeat expansion in the FMR1 gene, causing intellectual disability.
- Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is linked to FMR1 premutations, leading to neurodegeneration.
- Sensorimotor gating deficits, measured by pre-pulse inhibition (PPI), are observed in both FXS and FXTAS.
Purpose of the Study:
- To investigate sensorimotor gating (PPI) in FMR1 CGG knock-in (KI) mice, a model for FXTAS.
- To compare PPI deficits in FMR1 knock-out (KO) and CGG KI mice.
- To establish a novel phenotype in CGG KI mice for therapeutic development.
Main Methods:
- Utilized a quiet pre-pulse inhibition (PPI) protocol, mimicking human testing conditions.
- Assessed PPI in FMR1 knock-out (KO) mice.
- Evaluated PPI in CGG knock-in (KI) mice across different ages and compared them to wild-type (WT) controls.
Main Results:
- FMR1 KO mice exhibited significantly impaired PPI.
- CGG KI mice demonstrated an age-dependent impairment in PPI compared to WT controls.
- This study identified a novel phenotype in CGG KI mice relevant to FXTAS.
Conclusions:
- FMR1 KO mice show significant sensorimotor gating deficits.
- CGG KI mice display an age-dependent PPI impairment, mirroring FXTAS symptoms.
- The CGG KI mouse model offers a valuable tool for studying and developing therapies for FXTAS.
More Related Videos
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015